Strategic footprint AnazaoHealth operates a 503B outsourcing facility and a traditional 503A patient-specific pharmacy with national licensing across all 50 states, indicating a broad distribution capability and potential cross-sell opportunities to healthcare providers and hospitals seeking both compounding and outsourcing services.

Integrated channels With a technology stack spanning MATLAB, Wix eCommerce, Google Cloud, and collaborative tools, there is potential to offer streamlined ordering, digital formulary management, and secure patient-specific preparation workflows to pharmaceutical distributors and medical clinics.

Growth footprint Revenue is in the range of $100M-$250M and employee count is 201-500, signaling a mid-market scale with room to extend contracts through expanded compounding, nuclear medicine, pain management, and wellness pharmacy programs with hospital systems and specialty pharmacies.

Strategic partnerships Historical merger activity with Fagron and the focus on niche areas such as nuclear medicine and intrathecal preparations create opportunities to pursue collaborations with oncologists, radiology departments, and compounding-centric distributors seeking specialized formulations.

Compliance advantage Dual licensing as a 503B Outsourcing Facility and a 503A patient-specific pharmacy positions AnazaoHealth as a compliant partner capable of handling high-safety, regulated compounding workflows, appealing to healthcare systems requiring reliable sourcing for regulated medications.